Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia

Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia

HMG-CoA reductase inhibitors (statins) are effective lipid-altering drugs for the treatment of dyslipidemia in patients with type 2 diabetes mellitus. We conducted a randomized, double-blind, placebo-controlled, crossover design trial to determine the effects of simvastatin, 80 mg/day, on plasma lip...

Full description

Bibliographic Details
Main Authors:	Merle Myerson, Colleen Ngai, Jeffrey Jones, Steve Holleran, Rajasekhar Ramakrishnan, Lars Berglund, Henry N. Ginsberg
Format:	Article
Language:	English
Published:	Elsevier 2005-12-01
Series:	Journal of Lipid Research
Subjects:	very low density lipoproteins low density lipoproteins triglycerides 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors statins diabetes mellitus
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520328625

Similar Items

Antihyperlipidemic effects of apple peel extract in high-fat diet-induced hyperlipidemic rats
by: Retno Susilowati, et al.
Published: (2020-01-01)

Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
by: Margus Viigimaa, et al.
Published: (2014-01-01)

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
by: John S. Millar, et al.
Published: (2008-03-01)

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients[S]
by: Johanna Apro, et al.
Published: (2015-08-01)

The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
by: William L. Isley, et al.
Published: (2006-01-01)

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)

Necrotizing autoimmune myopathy: Clinicopathologic study from a single tertiary care centre
by: Sobiya Mahnaz Ayesha, et al.
Published: (2018-01-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

A genome-wide search for gene-by-obesity interaction loci of dyslipidemia in Koreans shows diverse genetic risk alleles
by: Moonil Kang, et al.
Published: (2019-12-01)

Avian apolipoprotein A-V binds to LDL receptor gene family members
by: Andrea Dichlberger, et al.
Published: (2007-07-01)

Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
by: Koska, Juraj, et al.
Published: (2016)

Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes1[S]
by: Juraj Koska, et al.
Published: (2016-05-01)

Long-term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells
by: Nassrin Dashti, et al.
Published: (2000-12-01)

Association of Hypertensive Retinopathy with different serum lipid parameters in patients of Essential Hypertension: A Hospital Based Study
by: Bishwa Nath Adhikari, et al.
Published: (2018-12-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Hypertriglyceridemia—Causes, Significance, and Approaches to Therapy
by: Leinys S. Santos-Baez, et al.
Published: (2020-09-01)

The inconspicuous health benefit of blood donation
by: Alhaji Bukar, et al.
Published: (2020-01-01)

Addition of binahong (Anredera cordifolia) leaf powder to diets to produce eggs with low cholesterol
by: Sri Kismiati, et al.
Published: (2020-03-01)

Atherogenic Index of Plasma an Indicator for Predicting Cardiovascular Risk in Addition to Endothelial Dysfunction in Type 2 Diabetic Subjects
by: Siva Prasad Palem, et al.
Published: (2018-06-01)

Effects of overexpression of the amino-terminal fragment of apolipoprotein B on apolipoprotein B and lipoprotein production
by: Zhaohui Li, et al.
Published: (2000-12-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)

The role of triglycerides and triglyceride/high-density lipoprotein ratio as a positive predictive factor in peripheral vascular disease
by: Rajendra Prasad Basavanthappa, et al.
Published: (2021-01-01)

Comparative Analysis between Martin’s Formula and Friedewald’s Formula with Direct Homogenous Assay for Estimating Low Density Lipoprotein Cholesterol Level in Nepalese Population
by: Bishal Raj Joshi, et al.
Published: (2021-06-01)

Atherogenic dyslipidemia
by: C N Manjunath, et al.
Published: (2013-01-01)

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
by: Jan Oscarsson, et al.
Published: (2017-08-01)

Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3
by: Chengliang Zhu, et al.
Published: (2017-11-01)

Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
by: Sunita Upreti, et al.
Published: (2019-01-01)

Comparison of Formula-Based Methods with Diverse TGL: VLDL-C Ratio for Calculating LDL-C in a Tertiary Care Hospital
by: MVP Chowdary
Published: (2021-08-01)

Lipid profile and oxidized lipoprotein levels in patients with acute myeloid leukemia
by: Nosrat Abedpor, et al.
Published: (2019-10-01)

The Apolipoprotein E ε4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study
by: Shan Wei, et al.
Published: (2020-03-01)

Lipid profile of healthy women during normal pregnancy
by: Diareme Margarita, et al.
Published: (2009-01-01)

HYPERTRIGLYCERIDEMIA AS A RISK FACTOR FOR CORONARY HEART DISEASE IN YOUNGER PAKISTANI POPULATION
by: Azhar Ijaz, et al.
Published: (2016-07-01)

A comparison between the effect of shisha and cigarette smoking on serum lipid profile of males in Nasiriyah City
by: Shatha Hamed Chwyeed
Published: (2018-01-01)

Study of Alterations in Lipid Profile After Burn Injury.
by: Dr.Asha Khubchandani, et al.
Published: (2017-06-01)

Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia[S]
by: Wu Yin, et al.
Published: (2012-01-01)

Characterization and quantitation of apolipoprotein B-100 by capillary electrophoresis
by: Ingrid D. Cruzado, et al.
Published: (1998-01-01)

Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans
by: Molly C. Carr, et al.
Published: (2004-03-01)

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
by: Holly E. Careskey, et al.
Published: (2008-02-01)

Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse
by: Chonglun Xie, et al.
Published: (2002-09-01)